Browse by Track

7-129 - Financial sustainability of a pharmacist-run comprehensive medication management program through direct medical billing using Current Procedural Terminology (CPT) codes

7-130 - Evaluation of a type 2 diabetes mellitus pharmacist-physician collaborative clinic on diabetes care measures and overall disease management in at-risk populations

7-131 - Impact of pharmacist intervention on medication adherence and measurable population health outcomes among patients in an urban primary care setting

7-132 - Use of asthma action plans in a rural outpatient clinic

7-133 - Evaluation of appropriate monitoring of potassium and creatinine in patients on spironolactone in a federally qualified health center

7-134 - Longer time in therapeutic blood pressure range protects against major adverse cardiovascular events and all-cause mortality in patients with hypertension: A post-hoc analysis of ACCORD

7-135 - Caffeine for the reversal of dipyridamole and regadenoson in pharmacologic stress testing

7-136 - Pharmacist-led Transition of Care (TOC) Program reduces 30- and 90-day readmissions in acute care setting

7-137 - Management of direct oral anticoagulants (DOACs) to lower adverse events in atrial fibrillation: the MODLE-AF study

7-138 - Evaluation on the clinical significance and level of acceptance of pharmacists’ recommendations in an adult renal ward in Hong Kong

7-139 - Cancellations of elective surgical procedures due to inadequate management of chronic medications

7-140 - Development of a stratification model for ambulatory oncology pharmacy services

7-141 - Cost-effectiveness of multidisciplinary care in chronic kidney disease

7-142 - Effectiveness of melatonin in preventing intensive care unit delirium

7-143 - Evaluation of drug company medical information websites on their quality of references cited for product efficacy data

7-144 - Risk information- safety communications across the pond

7-145 - Analysis of surrogate endpoints as the basis of approval or licensure by therapeutic area and approval pathway

7-146 - Indexing performance measure codes to enhance perceived value of evidence based practice center reports

7-147 - Empowerment of patients: Investigating the accessibility of patient resources from pharmaceutical companies websites

7-148 - An International Comparison: Qualifications, Training and Resources of Drug and Medicines Information Specialists in the US and UK

7-149 - Effectiveness and safety of secukinumab in plaque psoriasis and psoriatic arthritis

7-150 - Effectiveness of direct-acting antivirals for chronic hepatitis c patients in a Spanish cohort

7-151 - Reporting quality of survey research articles published in the pharmacy literature

7-152 - Epinephrine auto-injectors: a case for a prescription-to-over-the-counter switch

7-153 - Implementation of a pharmacy emergency preparedness program at a five hospital health-system

7-154 - Evaluation of the effect of Fluoroquinolone and Azoles combination on QTc

7-155 - Using procalcitonin to limit antimicrobial usage and fluid overload in heart failure patients

7-156 - Trends in antimicrobial resistance over five years in a large health system: a retrospective observational report

7-157 - Analyzing the evolution of cyber security as it relates to the pharmaceutical industry and identifying best practices for risk management

7-158 - Patient perception of digital pill technology related to medication nonadherence

7-159 - Cross-Validation of the ACE tool in Pharmacy Students

7-160 - Systematic review of current pharmaceutical industry clinical trials utilizing gene therapy

7-161 - Mortality in cancer patients with chemotherapy-induced anemia (CIA) and treated with erythropoiesis-stimulating agents (ESA): meta-analysis of randomized trials

7-162 - Endpoints in neoadjuvant non-small cell lung cancer clinical trials: historical trends, the emergence of pathological response, and the impact on clinical trial efficiency

7-163 - Factors affecting trial enrollment rate in hematology/oncology clinical trials inclusive of pediatric patients

7-164 - Use of everolimus and axitinib in metastatic renal cell carcinoma in a university hospital

7-165 - Analysis of DPYD variants in patients that suffer serious adverse events with fluoropyrimidine-based cancer treatment

7-166 - Blood cell count indexes as potential predictors of response to immune checkpoint inhibitors: focus on minority patients with non-small cell lung cancer

7-167 - Evaluation of the Utilization of Darbepoetin alfa for Sickle Cell Anemia

7-168 - Immune - related adverse events with immune checkpoint inhibitors: focus on minority patients with non-small cell lung cancer

7-169 - Analysis of current literature available regarding quality of survival (QOS) within oncology

7-170 - Pain referred by adult patients at different moments of the surgical process

7-171 - Comparing oral/transmucosal vs. parenteral agents for pain management in patients at end of life in hospice care

7-172 - Pediatrics, opioids, and pain assessment – evaluating the use of self-reported pain scale scores’ effect on opioid prescribing patterns in children

7-173 - Assessing the diagnostic accuracy of real-time alerts to detect as needed opioid orders with duplicate indications in the inpatient electronic health record

7-174 - Admission medication reconciliation service for pediatric and adolescent ward in a major acute hospital in Hong Kong

7-175 - Exposure-response analysis of the PARP inhibitor (PARPi) niraparib to help inform dose optimization for patients with ovarian cancer

7-176 - Impact of food and drug administration (FDA) pregnancy and lactation labeling rule (PLLR) on prescription drug and biological products labeling

7-177 - Systematic review of bulk drug substances for the 503B bulks list

7-178 - Knowledge of rare diseases in pharmacy students

7-179 - Implementation, utilization, and pharmacy student views on team-based and active learning in an introduction to drug information course: a comparison of two years

7-180 - Participation and engagement determinants in a biopharmaceutical industry elective course

7-181 - Roles and responsibilities of postdoctoral pharmaceutical industry fellows in Medical Affairs

7-182 - Assessment of PharmD students' interest in pursuing careers in the pharmaceutical industry and their knowledge of various functional areas

7-183 - Pharmacy students’ perceptions of patients based on citizenship status

7-184 - Factors influencing PharmD students’ post-graduate career preferences identified by a national survey

7-185 - The Value of Completing a Biopharmaceutical Industry Fellowship Program

7-186 - Evaluation of a novel pharmaceutical industry fellowship workshop for student pharmacists utilizing the Kirkpatrick four-level training evaluation model as a conceptual framework

7-187 - Identifying appealing career qualities and influences on PharmD students’ preferences for careers in the pharmaceutical industry from a national survey

7-188 - Evaluation of factors that contribute to pharmaceutical industry fellowship recruitment and program selection: A survey of current post-PharmD industry fellows

7-189 - Effect of mindfulness based stress reduction on health profession students in the United States

7-190 - Psychiatric disorders produced by apremilast: a case report of an adverse event

7-191 - Identifying opportunities to improve consumer use of social media as a tool for adverse event reporting

7-192 - Did I do that: analysis of iatrogenic and in-hospital medication errors reported to United States poison centers

7-193 - Prevalence and potential severity of antineoplastic drugs preparation errors detected during quality control of the process

7-194 - Examining the relationship between patient satisfaction and antibiotic prescribing for acute adult bronchitis in an ambulatory setting

7-195 - Analysis of the photoinitiators within an injection solution and the associated risks

7-196 - Relationship between oral contraceptive use and periodontal disease: Results from Korean National Health and Nutrition Examination Survey

7-197 - Development of a pharmacoeconomic clinical registry to evaluate the risks of unintended pregnancies and side effects resulting from drug interactions with hormonal oral contraceptives